In line with this, primary patient-derived leukemic MCL cells (defined as CD45+CD19+CD5+) expressed elevated surface levels of CD24 compared to B cells from healthy donors (CD45+CD19+) (Figure 1D). This evidence concerns the gene PTPRC and mantle cell lymphoma.